Detalhe da pesquisa
1.
Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial.
Lancet Neurol
; 20(11): 895-906, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687634